{
  "slug": "boston-biodevelopment-llc",
  "name": "Boston Biodevelopment Llc",
  "description": "Boston Biodevelopment is a premium boutique regulatory strategy consulting firm founded in 2009. They provide highly experienced regulatory professionals, including former heads of regulatory affairs, offering hands-on regulatory leadership and management throughout the development and approval of new therapies in biopharma, including biologics, small molecules, cell and gene therapies, and gene editing products.",
  "url": "https://optimly.ai/brand/boston-biodevelopment-llc",
  "websiteUrl": "https://bostonbiodevelopment.com/",
  "logoUrl": "https://logo.clearbit.com/bostonbiodevelopment.com",
  "baiScore": 52.5,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Regulatory Affairs Consulting",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-05T14:40:41.372Z",
  "verifiedVitals": {
    "website": "https://bostonbiodevelopment.com",
    "category": "Regulatory Affairs Consulting Firm",
    "what_it_does": "Boston Biodevelopment Llc is a regulatory strategy consulting firm that provides hands-on regulatory leadership and management throughout the development and approval of new therapies. They offer expertise in regulatory affairs across various therapeutic areas and modalities in biopharma, guiding the regulatory development of biologics, small molecules, cell and gene therapies, and gene editing products through the entire product lifecycle. Their consultants embed within client teams to help meet development goals.",
    "primary_audience": "Life sciences companies and biopharma organizations developing new therapies.",
    "core_product": "Regulatory strategy consulting services, including global regulatory strategy, health authority interactions, IND, INTERACT, PIP, orphan, PRIME, Advisory Committee, Fast Track, ILAP, MAA, BLA, Regulatory Intelligence, NDA, Label, Due Diligence, CTA, RMAT, IMPD, Interim Heads of Regulatory, US Agent & FDA Authorized Contact, Global Regulatory Strategists, Submission Management, and Regulatory Strategy Advisory Board.",
    "parent_ownership": null,
    "named_competitors": null
  },
  "intentTags": null,
  "businessProfileClaims": [],
  "timestamp": 1789902850407
}